Though fairly similar in clinical manifestation and age-at-onset of motor symptoms, PD patients with LRRK2 risk variants seem to show, on average, milder motor and non-motor symptoms compared with idiopathic PD patients [34]. This evidence concerns the gene LRRK2 and Parkinson disease.